Clinical trial

A Study of Therapeutic Amplitude-modulated Electromagnetic Fields in Advanced…

NCT00440570 · Pasche, Boris, M.D., Other · Completed

Key facts

NCT number NCT00440570
Title A Study of Therapeutic Amplitude-modulated Electromagnetic Fields in Advanced Tumors
Official title Treatment of Advanced Cancer With Amplitude-modulated Electromagnetic Fields of Low Intensity by Means of an Intrabuccal Probe
Acronym THBC001
Lead sponsor Pasche, Boris, M.D., Other
Collaborators Barbault, Alexandre, M.S.
Status Completed
Phase Early Phase 1
Study type Interventional
Conditions Cancer, Brain Tumor
Intervention type Device
Interventions Low levels of amplitude-modulated electromagnetic fields, Emitter of low levels of amplitude-modulated electromagnetic fields
Enrollment 2
Start date Oct 1, 2004
Primary completion Sep 1, 2006
Completion Dec 1, 2007
First posted Feb 27, 2007
Last update posted Jun 29, 2011
Countries Switzerland

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies